ROS-Responsive mPEG–PCL Nanoparticles for Co-Delivery of Paclitaxel Prodrug and R848 in Synergistic Chemo-Immunotherapy
Chemo-immunotherapy aims to integrate chemotherapy-induced antigen release with innate immune activation to achieve enhanced antitumor efficacy. However, the pharmacokinetic mismatch and systemic toxicity of free small molecules often compromise the...
Authors
- Shixian Lv (ORCID: https://orcid.org/0000-0001-5623-7224)
- Zhaofan Yang
- Linlin Liu
- Luyao Wang
- Qi Zhang
- Hao Meng
Publication Details
- Journal
- Biomaterials Science
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1039/d5bm01811k
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00